Literature DB >> 23829280

Atypical chronic lymphocytic leukemia with polyglandular autoimmune endocrinopathy type II: a complex profile.

Preetesh Jain1, Luis Baez-Vallecillo, Yang O Huh, Ohad Benjamini, Lynne Abruzzo, Susan O'Brien, Naveen Pemmaraju, Michael Keating, Robert F Gagel, Zeev Estrov.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 23829280      PMCID： PMC4102379          DOI： 10.3109/10428194.2013.813666

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  15 in total

1.  A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients.

Authors:  E H Kemp; R A Ajjan; E S Husebye; P Peterson; R Uibo; H Imrie; S H Pearce; P F Watson; A P Weetman
Journal:  Clin Endocrinol (Oxf)       Date:  1998-11       Impact factor: 3.478

2.  Non-HLA autoimmunity genetic factors contributing to Autoimmune Polyglandular Syndrome type II in Tunisian patients.

Authors:  Hajer Fourati; Dorra Bouzid; Olfa Abida; Najla Kharrat; Fatma Mnif; Samy Haddouk; Constantin Fesel; João Costa; Mourad Ben Ayed; Mohamed Abid; Ahmed Rebai; Carlos Penha-Gonçalves; Hatem Masmoudi
Journal:  Hum Immunol       Date:  2012-04-23       Impact factor: 2.850

3.  The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia.

Authors:  E Chapiro; I Radford-Weiss; C Bastard; I Luquet; C Lefebvre; E Callet-Bauchu; D Leroux; P Talmant; M-J Mozziconacci; F Mugneret; S Struski; S Raynaud; J Andrieux; C Barin; M Jotterand; H Mossafa; S Ramond; C Terré; E Lippert; F Berger; P Felman; H Merle-Béral; O A Bernard; F Davi; R Berger; F Nguyen-Khac
Journal:  Leukemia       Date:  2008-05-01       Impact factor: 11.528

4.  Clinical and immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders.

Authors:  Adrian Duek; Lev Shvidel; Andre Braester; Alain Berrebi
Journal:  Isr Med Assoc J       Date:  2006-12       Impact factor: 0.892

5.  Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.

Authors:  Vera Rebmann; Philipp Schütt; Dieter Brandhorst; Bertram Opalka; Thomas Moritz; Mohammad Reza Nowrousian; Hans Grosse-Wilde
Journal:  Clin Immunol       Date:  2007-01-10       Impact factor: 3.969

6.  The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia.

Authors:  H Nückel; M Switala; L Sellmann; P A Horn; J Dürig; U Dührsen; R Küppers; H Grosse-Wilde; V Rebmann
Journal:  Leukemia       Date:  2010-04-29       Impact factor: 11.528

7.  Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease.

Authors:  G Gambelunghe; A Falorni; M Ghaderi; S Laureti; C Tortoioli; F Santeusanio; P Brunetti; C B Sanjeevi
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

Review 8.  Autoantibodies in autoimmune polyendocrine syndrome type II.

Authors:  Alberto Falorni; Stefano Laureti; Fausto Santeusanio
Journal:  Endocrinol Metab Clin North Am       Date:  2002-06       Impact factor: 4.741

9.  Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells.

Authors:  Andrew M Hall; Mark A Vickers; Ewan McLeod; Robert N Barker
Journal:  Blood       Date:  2004-07-29       Impact factor: 22.113

10.  DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells.

Authors:  J P Houchins; T Yabe; C McSherry; F H Bach
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.